1. Home
  2. INOD vs ADPT Comparison

INOD vs ADPT Comparison

Compare INOD & ADPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INOD
  • ADPT
  • Stock Information
  • Founded
  • INOD 1988
  • ADPT 2009
  • Country
  • INOD United States
  • ADPT United States
  • Employees
  • INOD N/A
  • ADPT N/A
  • Industry
  • INOD EDP Services
  • ADPT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • INOD Technology
  • ADPT Health Care
  • Exchange
  • INOD Nasdaq
  • ADPT Nasdaq
  • Market Cap
  • INOD 1.2B
  • ADPT 1.4B
  • IPO Year
  • INOD 1993
  • ADPT 2019
  • Fundamental
  • Price
  • INOD $50.00
  • ADPT $11.80
  • Analyst Decision
  • INOD Strong Buy
  • ADPT Strong Buy
  • Analyst Count
  • INOD 4
  • ADPT 7
  • Target Price
  • INOD $57.50
  • ADPT $10.57
  • AVG Volume (30 Days)
  • INOD 2.9M
  • ADPT 2.2M
  • Earning Date
  • INOD 08-07-2025
  • ADPT 07-31-2025
  • Dividend Yield
  • INOD N/A
  • ADPT N/A
  • EPS Growth
  • INOD 1293.88
  • ADPT N/A
  • EPS
  • INOD 1.08
  • ADPT N/A
  • Revenue
  • INOD $202,301,000.00
  • ADPT $189,527,000.00
  • Revenue This Year
  • INOD $44.28
  • ADPT $24.46
  • Revenue Next Year
  • INOD $22.64
  • ADPT $20.25
  • P/E Ratio
  • INOD $46.58
  • ADPT N/A
  • Revenue Growth
  • INOD 114.21
  • ADPT 8.61
  • 52 Week Low
  • INOD $13.02
  • ADPT $3.30
  • 52 Week High
  • INOD $71.00
  • ADPT $12.43
  • Technical
  • Relative Strength Index (RSI)
  • INOD 57.80
  • ADPT 66.39
  • Support Level
  • INOD $46.15
  • ADPT $11.17
  • Resistance Level
  • INOD $52.60
  • ADPT $12.43
  • Average True Range (ATR)
  • INOD 3.95
  • ADPT 0.60
  • MACD
  • INOD 0.06
  • ADPT 0.03
  • Stochastic Oscillator
  • INOD 81.64
  • ADPT 75.10

About INOD Innodata Inc.

Innodata Inc is a data engineering company. It is helping companies deploy and integrate AI into their operations and products and providing AI-enabled industry platforms. The Company's operations are classified in three reporting segments: Digital Data Solutions (DDS), Synodex and Agility. Key revenue is generated from DDS segment provides AI data preparation services, collecting or creating training data, annotating training data, and training AI algorithms for its customers, and AI model deployment and integration. It also provides a range of data engineering support services including data transformation, data curation, data hygiene, data consolidation, data extraction, data compliance, and master data management.

About ADPT Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).

Share on Social Networks: